Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 30 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-30-2022-3

Zydus Lifesciences Limited has informed the Exchange about press release dated 30-Aug-2022 titled Zydus announces Phase IV DREAM-CKD trial to generate Real World Evidence of Desidustat in patients with Chronic Kidney Disease induced anemia

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases